[go: up one dir, main page]

EE200200596A - Mobiliseeriva toimega preparaat - Google Patents

Mobiliseeriva toimega preparaat

Info

Publication number
EE200200596A
EE200200596A EEP200200596A EEP200200596A EE200200596A EE 200200596 A EE200200596 A EE 200200596A EE P200200596 A EEP200200596 A EE P200200596A EE P200200596 A EEP200200596 A EE P200200596A EE 200200596 A EE200200596 A EE 200200596A
Authority
EE
Estonia
Prior art keywords
preparation
mobilizing effect
haematopoietic
mobilizing
effect
Prior art date
Application number
EEP200200596A
Other languages
English (en)
Estonian (et)
Inventor
Ferro Laura
Porta Roberto
Iacobelli Massimo
Massimo Gianni Alessandro
Carlo Stella Carmelo
Original Assignee
Gentium Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentium Spa filed Critical Gentium Spa
Publication of EE200200596A publication Critical patent/EE200200596A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
EEP200200596A 2000-04-18 2001-04-10 Mobiliseeriva toimega preparaat EE200200596A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00830293A EP1147777A1 (en) 2000-04-18 2000-04-18 Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
PCT/EP2001/004105 WO2001078761A2 (en) 2000-04-18 2001-04-10 Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors

Publications (1)

Publication Number Publication Date
EE200200596A true EE200200596A (et) 2004-04-15

Family

ID=8175292

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200596A EE200200596A (et) 2000-04-18 2001-04-10 Mobiliseeriva toimega preparaat

Country Status (31)

Country Link
US (1) US20040131588A1 (xx)
EP (3) EP1147777A1 (xx)
JP (1) JP5205668B2 (xx)
KR (1) KR100849491B1 (xx)
CN (1) CN1183962C (xx)
AT (2) ATE310532T1 (xx)
AU (2) AU2001258322B2 (xx)
BG (1) BG107203A (xx)
CA (1) CA2406179C (xx)
CY (1) CY1104971T1 (xx)
CZ (1) CZ20023426A3 (xx)
DE (2) DE60115222T2 (xx)
DK (2) DK1621207T3 (xx)
EE (1) EE200200596A (xx)
ES (2) ES2335776T3 (xx)
HR (1) HRP20020835A2 (xx)
HU (1) HUP0300560A3 (xx)
IL (1) IL152328A (xx)
IS (1) IS2171B (xx)
MX (1) MXPA02010346A (xx)
NO (1) NO20024988L (xx)
NZ (1) NZ522016A (xx)
PL (1) PL358100A1 (xx)
PT (1) PT1621207E (xx)
RO (1) RO121006B1 (xx)
RU (1) RU2248216C2 (xx)
SI (1) SI21079B (xx)
SK (1) SK14892002A3 (xx)
UA (1) UA73566C2 (xx)
WO (1) WO2001078761A2 (xx)
ZA (1) ZA200208413B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8771663B2 (en) 2000-04-18 2014-07-08 Gentium Spa Formulation having mobilising activity
KR101192136B1 (ko) * 2003-07-29 2012-10-16 돔페 파르마 에스.피.에이. 혈액 줄기 세포의 동원에 유효한 ｇ-ｃｓｆ와 ｐｌｇｆ의조합 약제
JP2007535479A (ja) 2003-08-13 2007-12-06 チルドレンズ ホスピタル メディカル センター ＧＴＰａｓｅを調節するためのキメラペプチド
US7417026B2 (en) 2003-08-13 2008-08-26 Children's Hospital Medical Center Mobilization of hematopoietic cells
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
RU2376985C1 (ru) * 2008-07-17 2009-12-27 Владислав Николаевич Ласкавый Средство для активации стволовых клеток
CN107007617A (zh) 2010-11-12 2017-08-04 真蒂奥姆责任有限公司 去纤维蛋白多核苷酸用于预防和/或治疗移植物抗宿主病(gvhd)
SG11201408481UA (en) 2012-06-22 2015-01-29 Gentium Spa Euglobulin-based method for determining the biological activity of defibrotide
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
CN106567694A (zh) * 2016-11-14 2017-04-19 北京国泰通源技术有限公司 智能控水短节
CA3055174C (en) * 2018-01-12 2021-05-18 Cellmig Biolabs Inc. Methods for generation of cytocapsulae and cytocapsular tubes
JP7270762B2 (ja) 2019-11-13 2023-05-10 富士フイルム株式会社 加飾フィルム、成型物、及び電子デバイス

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899481A (en) 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
IT1206341B (it) 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4694134A (en) 1985-05-28 1987-09-15 Ajax Magnethermic Corporation Apparatus for overheating edges of skelp for the production of compression welded pipe
IT1190313B (it) 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
US5223609A (en) 1986-04-17 1993-06-29 Crinos Industria Farmacobiologica S.P.A. Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
JP2907447B2 (ja) * 1988-08-24 1999-06-21 中外製薬株式会社 抗血栓剤
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
JP3021906B2 (ja) * 1992-01-28 2000-03-15 松下電器産業株式会社 電動調理機
RU2136667C1 (ru) * 1995-04-18 1999-09-10 Научно-исследовательский институт фармакологии РАМН Производные 2-меркаптобензимидазола, обладающие противоишемической, антиаритмической и противофибрилляторной активностью
JPH08127539A (ja) * 1994-10-31 1996-05-21 Ajinomoto Co Inc ヒトｉｌ−１１を含有する末梢血幹細胞増加剤
WO1996016987A1 (en) * 1994-11-30 1996-06-06 Chugai Seiyaku Kabushiki Kaisha Thrombocytotic factor
DE69733694T2 (de) * 1996-07-10 2006-07-06 Muramatsu, Takashi, Nagoya Verwendung von proteinen aus der mk familie als hämatopoietischer faktor
AU1705599A (en) * 1997-11-26 1999-06-15 Allegheny University Of The Health Sciences Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
US6573372B2 (en) * 1999-01-07 2003-06-03 Heska Corporation Feline immunoglobulin E molecules and compositions there of

Also Published As

Publication number Publication date
DK1276497T3 (da) 2006-03-27
DE60115222D1 (de) 2005-12-29
EP1276497A2 (en) 2003-01-22
KR100849491B1 (ko) 2008-07-31
US20040131588A1 (en) 2004-07-08
DK1621207T3 (da) 2010-02-01
ES2335776T3 (es) 2010-04-05
SI21079B (sl) 2006-08-31
UA73566C2 (en) 2005-08-15
WO2001078761A2 (en) 2001-10-25
RO121006B1 (ro) 2006-11-30
NO20024988D0 (no) 2002-10-16
NZ522016A (en) 2004-10-29
CA2406179C (en) 2012-03-27
CA2406179A1 (en) 2001-10-25
PT1621207E (pt) 2009-12-28
RU2248216C2 (ru) 2005-03-20
IS2171B (is) 2006-11-15
ZA200208413B (en) 2003-10-17
EP1147777A1 (en) 2001-10-24
DE60115222T2 (de) 2006-08-10
IL152328A0 (en) 2003-05-29
ATE310532T1 (de) 2005-12-15
RU2002130719A (ru) 2004-03-27
KR20030010603A (ko) 2003-02-05
AU5832201A (en) 2001-10-30
HRP20020835A2 (en) 2005-10-31
IS6581A (is) 2002-10-14
EP1276497B1 (en) 2005-11-23
PL358100A1 (en) 2004-08-09
WO2001078761A3 (en) 2002-01-24
DE60140015D1 (de) 2009-11-05
ATE443524T1 (de) 2009-10-15
IL152328A (en) 2009-12-24
JP2004500437A (ja) 2004-01-08
CY1104971T1 (el) 2010-03-03
HUP0300560A2 (hu) 2003-06-28
HUP0300560A3 (en) 2005-07-28
SI21079A (sl) 2003-06-30
EP1621207A3 (en) 2006-11-22
JP5205668B2 (ja) 2013-06-05
CN1434719A (zh) 2003-08-06
EP1621207B1 (en) 2009-09-23
NO20024988L (no) 2002-12-02
CN1183962C (zh) 2005-01-12
SK14892002A3 (sk) 2003-06-03
MXPA02010346A (es) 2004-09-06
ES2252227T3 (es) 2006-05-16
AU2001258322B2 (en) 2006-03-16
EP1621207A2 (en) 2006-02-01
BG107203A (bg) 2003-05-30
CZ20023426A3 (cs) 2003-05-14

Similar Documents

Publication Publication Date Title
AU2001269688A1 (en) Combination containing an antifolate and methylmalonic acid lowering agent
EE200200596A (et) Mobiliseeriva toimega preparaat
ES2160577T3 (es) Nuevos esteres de aminoalcoholes biciclicos y triciclicos, su preparacion y su utilizacion en medicamentos.
GB9807639D0 (en) Anti-inflammatory agents
DE69905368D1 (en) Oxydiertes thymosin beta 4
DK1244408T3 (da) Absorberende artikel, hvor hovedabsorptionsdelen er i den forreste del
MXPA03000188A (es) Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales.
IL158155A0 (en) Use of erythropoietin to ameliorate chemotherapy-induced toxicity in vivo
WO2001089536A3 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
AU2002332488A8 (en) R-bambuterol, its preparation and therapeutic uses
YU45591A (sh) Novi retinoidi
EP1023901A4 (en) MEDICINES FOR HEPATITIS C AND THE USE THEREOF
YU79802A (sh) Formulacija sa aktivnošću mobilizacije
EP1123100A4 (en) MEMORY IMPROVEMENT BY ADMINISTRATION OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION AND 3-BETA-ESTERS THEREOF
FI851365L (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
JPS6461429A (en) Remedy for cancer
ECSP003380A (es) Derivados de campotecina con actividad antitumoral